# Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease

> **NCT00002827** · PHASE3 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 294 (actual)

## Conditions studied

- Cardiac Toxicity
- Lymphoma

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **BIOLOGICAL:** filgrastim
- **DRUG:** dexrazoxane hydrochloride
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** vincristine sulfate
- **RADIATION:** low-LET cobalt-60 gamma ray therapy
- **RADIATION:** low-LET electron therapy
- **RADIATION:** low-LET photon therapy

## Key facts

- **NCT ID:** NCT00002827
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-10
- **Primary completion:** 2004-10
- **Final completion:** 2008-06
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2013-08-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002827, "Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00002827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*